Contents

Search


organophosphate toxicity

Etiology: absorption through skin Pathology: - cholinesterase inhibition Clinical manifestations: 1) bradycardia 2) bronchorrhea & wheezing 3) pulmonary edema 4) miosis 5) fasciculations, rarely seizures 6) abdominal pain, nausea, vomiting, diarrhea 7) urination, lacrimation, salivation, diaphoresis 8) hypoxemia, confusion Acronyms for manifestations 1) SLUDGE a) Salivation b) Lacrimation c) Urination d) Defecation e) GI upset f) Emesis 2) DUMBELS a) Diarrhea b) Urination c) Miosis d) Bronchospams e) Emesis f) Lacrimation g) Salivation Laboratory: 1) plasma cholinestesase & erythrocyte cholinesterase levels are < 50% of normal 2) serial plasma cholinesterase activity to confirm trend towards normal Special laboratory: - pulse oximetery - electrocardiogram, telemetry Complications: - patients may drown in their own secretions - cognitive impairment with long-term exposure? [4] Management: 1) general - health care workers should be gowned & gloved - remove patient's clothing - shampoo hair - clean all skin surfaces - resolve respiratory symptoms - do not wait for test results to start treatment in seriously ill patients 2) ventilatory support as needed 3) pharmaceutical agents a) atropine 0.02-0.05 mg/kg IV every 15 minutes - treats muscarinic effects - titrate dose to minimize dyspnea, airway resistance, & bronchial secretions b) pralidoxime 20-50 mg/kg IV every 2-12 hours - treatment of CNS toxicity - continuous infusion 1g/hour may be better - addresses both nicotinic & muscarinic effects c) Duodote autoinjector (atropine, pralidoxime) d) benzodiazepine (diazepam, lorazepam) for seizures

General

toxicity; poisoning; overdose

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 1153-55
  2. Pawar KC et al, Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphate pesticide poisoning: A randomized controlled trial. Lancet 2006, 368:2136 PMID: 17174705
  3. Medical Knowledge Self Assessment Program (MKSAP) 14, American College of Physicians, Philadelphia 2006
  4. Baldi I et al. Neurobehavioral effects of long-term exposure to pesticides: Results from the 4-year follow-up of the PHYTONER Study. Occup Environ Med 2010 Nov 22 PMID: 21097948 http://oem.bmj.com/content/early/2010/10/18/oem.2009.047811